Please assess the completion status of the following clinical trial:

Trial Title: Bevacizumab (Avastin) Induced Hypertension and Correlation With Tumor Response, a Chart Review

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients treated with bevacizumab, with or without chemotherapy, with a wide variety of metastatic malignancies.~* Patients with and without pre-existing hypertension treated with bevacizumab plus or minus chemotherapy with a wide variety of metastatic malignancies.~Exclusion Criteria:~* Not specified.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).